Home Capital Broker's Calls

Singapore Medical Group kept at ‘buy’ for capturing market share from competitors

PC Lee
PC Lee5/16/2018 12:58 PM GMT+08  • 2 min read
Singapore Medical Group kept at ‘buy’ for capturing market share from competitors
SINGAPORE (May 16): RHB Research says Singapore Medical Group must be doing something right to capture market share in the private medical practice space from its competitors.
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

SINGAPORE (May 16): RHB Research says Singapore Medical Group must be doing something right to capture market share in the private medical practice space from its competitors.

In addition, SW1, the aesthetic and plastic surgery clinic that was acquired at the end of March, is already profitable and is expected to contribute positively to the group’s bottomline from 2Q18.

RHB Research expects steady quarters ahead with organic growth still strong at double-digit levels despite an estimated drop in medical tourism numbers.

For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
×
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.
Unlock unlimited access to premium articles with less than $9 per month. Subscribe Now